BioMarin Pharmaceutical Inc.

8-K/A Other events Jul 13, 2026 8-K Director or officer change; Shareholder vote results Jun 4, 2026 10-Q Quarter ended 2026-03-31 May 5, 2026 8-K Results of operations (earnings release) May 4, 2026 8-K Entered a material agreement; Completed an acquisition or disposition; Took on a direct financial obligation; Regulation FD disclosure Apr 27, 2026 8-K Other events Apr 23, 2026 8-K Other events Mar 16, 2026 10-K Fiscal year ended 2025-12-31 Feb 26, 2026 8-K Results of operations (earnings release) Feb 23, 2026 8-K Entered a material agreement; Took on a direct financial obligation; Regulation FD disclosure Feb 12, 2026 8-K Regulation FD disclosure Jan 29, 2026 8-K Results of operations (earnings release); Regulation FD disclosure; Other events Jan 26, 2026 8-K Results of operations (earnings release) Jan 12, 2026 8-K Other events Dec 22, 2025 8-K Entered a material agreement; Regulation FD disclosure Dec 19, 2025 8-K Director or officer change Dec 17, 2025 10-Q Quarter ended 2025-09-30 Oct 28, 2025 8-K Results of operations (earnings release) Oct 27, 2025 8-K Results of operations (earnings release) Oct 7, 2025 8-K Director or officer change Aug 11, 2025 10-Q Quarter ended 2025-06-30 Aug 5, 2025 8-K Results of operations (earnings release) Aug 4, 2025 8-K Director or officer change Aug 1, 2025 8-K Director or officer change; Shareholder vote results May 22, 2025 8-K Entered a material agreement; Regulation FD disclosure May 16, 2025 10-Q Quarter ended 2025-03-31 May 2, 2025 8-K Results of operations (earnings release) May 1, 2025 8-K Modified rights of security holders; Amended charter or bylaws Mar 3, 2025 8-K Director or officer change Feb 24, 2025 10-K Fiscal year ended 2024-12-31 Feb 24, 2025 8-K Results of operations (earnings release) Feb 19, 2025 10-Q Quarter ended 2024-09-30 Oct 31, 2024 8-K Results of operations (earnings release) Oct 29, 2024 8-K Regulation FD disclosure Sep 24, 2024 8-K Entered a material agreement; Took on a direct financial obligation Sep 4, 2024 8-K Exit or disposal costs Aug 28, 2024 8-K Director or officer change Aug 22, 2024 10-Q Quarter ended 2024-06-30 Aug 5, 2024 8-K Results of operations (earnings release) Aug 5, 2024 8-K Shareholder vote results May 24, 2024